Actavis Plans Job Cuts, China Expansion for Allergan

Actavis Plc, which this month agreed to buy Allergan Inc. for $66 billion, plans to cut employees and expand in China, executives from the companies said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.